Taidoc Technology Corporation (4736) AI Stock Analysis

Taidoc Technology Corporation

(TWSE:4736)

Select Model

Rating:75Outperform

Price Target:TWD 142.00▲(9.23% Upside)

Action:initiatedcoverage

Date:11/10/26

The score is supported primarily by strong financial health and very attractive valuation. Weak recent revenue momentum, uneven cash conversion, and negative short-term technical momentum materially offset those strengths.

Positive Factors

Conservative Balance SheetLow and stable leverage, together with growing equity, gives Taidoc financial flexibility to support operations and pursue opportunities without excessive balance-sheet strain. This conservative structure should improve resilience through softer demand and reduce the risk that debt limits future capital allocation.

Negative Factors

Multi-Year Revenue DeclineSeveral years of falling revenue point to a persistent demand or product-mix challenge rather than a single-period fluctuation. Continued contraction can reduce scale benefits, limit reinvestment capacity, and make future profit growth increasingly dependent on cost control instead of expanding market demand.

Taidoc Technology Corporation (4736) vs. SPDR S&P 500 ETF (SPY)

Market Cap: TWD 13.36B
Dividend Yield: 3.90%
Average Volume (3M): 296.00K
Price to Earnings (P/E): 5.0
Beta (1Y): 0.26
Revenue Growth: -0.47%
EPS Growth: 45.76%
Country: TW
Employees: 654
Sector: General
Sector Strength: 55
Industry: Medical - Devices

Taidoc Technology Corporation Business Overview & Revenue Model

Company Description

TaiDoc Technology Corporation, established in 1998 and based in New Taipei City, Taiwan, is a leading global producer and distributor of a wide array of medical devices. The company's comprehensive product catalog features advanced in vitro diagnosti...

Taidoc Technology Corporation Financial Statement Overview

Summary

Strong balance sheet and profitability support the score, with low leverage, improved net income and ROE, and solid margins. Revenue declines and uneven cash conversion limit the score.

Income Statement

78Positive

Balance Sheet

91Very Positive

Cash Flow

75Positive

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	4.23B	4.20B	4.64B	4.81B	9.63B	6.49B
Gross Profit	1.80B	1.93B	2.05B	2.07B	5.65B	3.21B
EBITDA	930.01M	1.10B	1.65B	1.19B	4.61B	2.74B
Net Income	2.56B	1.44B	1.16B	1.02B	3.38B	1.97B
Balance Sheet
Total Assets	14.38B	12.78B	12.24B	11.91B	12.90B	10.52B
Cash, Cash Equivalents and Short-Term Investments	6.26B	5.23B	4.94B	4.73B	5.03B	3.08B
Total Debt	941.14M	1.16B	1.05B	1.09B	636.31M	1.26B
Total Liabilities	3.02B	2.66B	2.72B	2.65B	2.91B	2.89B
Stockholders Equity	11.01B	9.79B	9.09B	8.90B	9.67B	7.39B
Cash Flow
Free Cash Flow	780.11M	602.17M	-536.61M	1.06B	2.70B	1.59B
Operating Cash Flow	1.05B	853.39M	-181.37M	1.17B	3.21B	1.92B
Investing Cash Flow	152.35M	-298.12M	-52.38M	129.57M	-573.83M	-675.07M
Financing Cash Flow	-1.20B	-895.55M	-977.50M	-1.46B	-1.77B	-604.80M

Taidoc Technology Corporation Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

TW:4736 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TW:4736	75Outperform	TWD 13.26B	5.04	―	3.90%	-0.47%	45.76%
TW:6667	64Neutral	TWD 12.62B	12.58	―	4.56%	28.55%	55.47%
TW:4104	61Neutral	TWD 13.58B	14.58	―	5.97%	11.09%	7.11%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%

* General Sector Average

Performance Comparison

TW:4736 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
TW:4736	Taidoc Technology Corporation	130.00	21.53	19.84%
TW:4104	Excelsior Medical Co., Ltd.	72.00	-5.81	-7.47%
TW:6667	Trusval Technology Co., Ltd.	249.00	27.69	12.51%
TW:6748	ACRO Biomedical Co., Ltd.	169.50	111.12	190.35%
TW:7780	Daiken Biomedical Co., Ltd.	15.10	-2.15	-12.45%
TW:7853	Cheng Mei Instrument Technology Co., Ltd.	332.50	266.00	400.00%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 09, 2026

Taidoc Technology Corporation AI Stock Analysis